Theriva Biologics Inc (TOVX): A bit of DD from the 10Q: SYN-004...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Theriva Biologics Inc (TOVX)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	3
Posts	54
Boards Moderated	0
Alias Born	03/22/2012

Re: big orange post# 7686

Thursday, 11/16/2017 4:17:19 PM

Thursday, November 16, 2017 4:17:19 PM

A bit of DD from the 10Q:

SYN-004

- Expect to share additional results regarding several exploratory endpoints from Phase 2b proof-of-concept clinical trial designed to evaluate SYN-004’s (ribaxamase) ability to protect the gut microbiome from opportunistic bacterial infections and prevent the emergence of antimicrobial resistance (AMR) in the gut microbiome (4Q 2017)

- Plan to continue collaborative discussions with the FDA to solidify details and components of the drug development plan and regulatory pathway towards marketing approval for SYN-004 (ribaxamase) (1Q 2018)

- Plan to initiate Phase 3 clinical trial(s) (2018)

Worth mentioning they have BTD designation for SYN-004.
Patience is golden with this one imo.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent TOVX News

Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 01:10:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:10:38 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:07:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:01:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:00:21 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:00:19 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:15:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 11:10:42 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 10:05:12 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 10:06:35 AM
Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 08/16/2023 09:24:26 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/15/2023 01:53:41 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/14/2023 09:11:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 08:30:38 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 01:03:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 12:10:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 01:22:02 PM
Another Biotech Stealing The Premarket Spotlight • AllPennyStocks.com • 06/28/2023 02:15:00 PM

More TOVX News

InvestorsHub NewsWire

FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM

Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM

Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM

Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM

North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM

Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow